Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine
Jarzabek, Z.; Kańtoch, M.
Przeglad Epidemiologiczny 38(3): 323-326
1984
ISSN/ISBN: 0033-2100 PMID: 6098935 Document Number: 229918
Document emailed within 1 workday
Related Documents
Petrescu, A.; Mihail, A.; Samuel, I.; Teodosiu, O.; Isaia, G.; Ganea, E.; Motaş, C. 1979: Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology Virologie 30(2): 109-115Mazur, B. 1971: Poliovirus-neutralizing antibodies in stools of poliomyelitis patients Przeglad Epidemiologiczny 25(2): 241-249
Shen, Y.; Zhao, Y.; Liu, D. 1995: Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province Zhonghua Yu Fang Yi Xue Za Zhi 29(6): 335-338
Hennessey, K.A.; Lago, H.; Diomande, F.; Akoua-Koffi, C.; Caceres, V.M.; Pallansch, M.A.; Kew, O.M.; Nolan, M.; Zuber, P.L.F. 2005: Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire Journal of Infectious Diseases 192(12): 2124-2128
Lotti, F. 1970: Evaluation of the allergic and immunological state persons vaccinated at birth with Salvioli's diffusing vaccine La Clinica Pediatrica 52(9): 377-380
Friedrich, F. 2000: Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus Acta Virologica 44(2): 109-117
Dowdle, W.R.; Wolff, C.; Sanders, R.; Lambert, S.; Best, M. 2004: Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification? Bulletin of the World Health Organization 82(1): 59-62
Chowdhary, R.; Dhole, T.N. 2008: Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India Journal of Medical Virology 80(8): 1477-1488
Dutta, S.K.; Shipley, W.D. 1975: Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine American Journal of Veterinary Research 36(4 Part 1): 445-448
Korol, O.I.; Odintsov, A.I.; Krivokhizh, V.N. 1994: Clinical course of tuberculosis in young children, vaccinated and non-vaccinated with BCG vaccine Problemy Tuberkuleza 6: 21-24
Mazurowska-Magdzik, W. 1976: Levels of antibodies to typhoid fever in vaccinated and non-vaccinated children in the course of other diseases with the exception of salmonelloses Przeglad Epidemiologiczny 30(1): 11-19
Más Lago, P.; Díaz, J.; Díaz Gonzalez, M.; Goyenechea Hernández, A.; Barrio Olivera, J.; Fonseca Quintana, M.; Morier Díaz, L.; Sarmiento Pérez, L.; Palomera Puente, R. 2005: Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine Revista Cubana de Medicina Tropical 57(2): 111-119
Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants Journal of Infectious Diseases 208(4): 672-678
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Lu, T.L. 1983: Neutralizing activity of HBsAg-positive sera with different titers Zhonghua Liu Xing Bing Xue Za Zhi 4(6): 324-325
Omenda, M.M.; Milligan, C.; Odem-Davis, K.; Nduati, R.; Richardson, B.A.; Lynch, J.; John-Stewart, G.; Overbaugh, J. 2013: Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection Journal of Acquired Immune Deficiency Syndromes 64(2): 163-166
Solianok, L.D.; Bliznichenko, A.G. 1971: Neutralizing activity of normal human sera in relation to typhoid phages Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(12): 121-125
Darwish, M.A.; Ibrahim, A.H. 1971: Survey for antibodies to arboviruses in Egyptian sera. I. West Nile virus antihemagglutinins in human and animal sera Journal of the Egyptian Public Health Association 46(2): 61-70
Gherardin, A.; Lau, S. 2007: Intradermal rabies vaccine Medical Journal of Australia 187(1): 58-59